Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 380,229 shares at $12.80 ($4.9M) on 2022-12-02, disclosed to the SEC on 2022-12-02.
Open-market sale of $4.9M BCRX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 214,917 | $2.8M | 56.9% |
| 2 | $12.80 | 82,656 | $1.1M | 21.5% |
| 3 | $12.80 | 82,656 | $1.1M | 21.5% |
| Total | $12.91 avg | 380,229 | $4.9M | 100% |
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |
| BCRX | SELL | 2020-12-17 | $2.2M | — | Filing → |